Prevention of Invasive Pneumococcal Disease Among Black or African American Children With and Without Sickle Cell Disease in the United States After Introduction of 13‐Valent Pneumococcal Conjugate Vaccine, 2005 Through 2019

Documenti analoghi

• Clinical Features and Outcomes of Pneumococcal Bacteremia in Children With Sickle Cell Disease in the Pneumococcal Conjugate Vaccine Era
  di: Marianne E. Yee, et al.
  Pubblicazione: (2025)
• Medication Utilization Among Children With Sickle Cell Disease in the United States
  di: Abiodun John Ologunowa, et al.
  Pubblicazione: (2025)
• Meeting the Challenge: Prevention of Pneumococcal Disease with Conjugate Vaccines
  di: Irma Gabriela Echániz Avilés
  Pubblicazione: (2001)
• Optimizing Transcranial Doppler Screening for Stroke Prevention in Young African Children With Sickle Cell Disease
  di: Derby Tembo, et al.
  Pubblicazione: (2025)
• Pregnancy‐ and Disease‐Related Morbidity Among Medicaid Enrollees With Sickle Cell Disease
  di: Mariam Kayle, et al.
  Pubblicazione: (2025)